Azithromycin in gonorrhoea. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Azithromycin in gonorrhoea.

Int J STD AIDS. 1996;7 Suppl 1:2-4. Unique Identifier : AIDSLINE MED/96230311
Waugh MA; Leeds General Infirmary, UK.

Abstract: The clinical applications of azithromycin in gonorrhoea, often complicated by simultaneously acquired infection with Chlamydia trachomatis, are reviewed in this paper. Clinical trails from major centres in Europe are compared with a large, more recent US study. At the present time, azithromycin is recommended throughout the world as a useful antibiotic in treatment of gonorrhoea. It has several advantages in that it can be given as single-dose therapy, it can be given where the causative pathogen of urethritis/cervicitis is uncertain, and it is often, therefore, most useful in acute therapy where there is no immediate microbiological back-up. All these considerations are reviewed in detail.
Keywords: Antibiotics, Macrolide/*ADMINISTRATION & DOSAGE Azithromycin/*ADMINISTRATION & DOSAGE Chlamydia Infections/COMPLICATIONS/DRUG THERAPY Clinical Trials Female Gonorrhea/COMPLICATIONS/*DRUG THERAPY Human Male Pregnancy Treatment Outcome JOURNAL ARTICLE REVIEW REVIEW LITERATUREKWDantibiotics,macrolide/KWDadministration&dosageazithromycin/KWDadministration&dosagechlamydiainfections/complications/drugtherapyclinicaltrialsfemalegonorrhea/complications/KWDdrugtherapyhumanmalepregnancytreatmentoutcomejournalarticlereviewreviewliterature
961030
M96A1422

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .